Zhou F, Pan T, Li X, Du F, et al. Exploration of efficacy and safety of combined therapy of basiliximab with ruxolitinib for grade 3-4 steroid-refractory acute graft-versus-host disease: a registered clinical trial (NCT05021276). Bone Marrow Transplant 2023 May 30. doi: 10.1038/s41409-023-02005.
PMID: 37253803